Clinical Trials Directory

Trials / Sponsors / Sutro Biopharma, Inc.

Sutro Biopharma, Inc.

Industry · 7 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Head and Neck Squamous Cell Carcinoma HNSCC, Non-Small Cell Lung Cancer NSCLC, Esophageal Cancer
Phase 12025-11-07
TerminatedLuveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::
Acute Myeloid Leukemia (AML)
Phase 1 / Phase 22024-12-04
WithdrawnStudy to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer
Lung Cancer, Lung Cancer Metastatic, Lung Cancer, Nonsmall Cell
Phase 22024-08-21
TerminatedREFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Cho
Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer
Phase 2 / Phase 32023-07-12
TerminatedA Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in
Ovarian Cancer, Ovarian Carcinoma, Ovary Cancer
Phase 12022-03-22
CompletedStudy of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Canc
Ovarian Cancer, Ovarian Carcinoma, Ovary Cancer
Phase 12019-02-01
CompletedStudy of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies
B-cell Lymphoma, Non Hodgkin Lymphoma, Multiple Myeloma
Phase 12018-02-22